Surveillance and prevention of healthcare-associated infections: best practices to prevent ventilator-associated events

Leonardo Lorente,Joan Sabater-Riera,Jordi Rello
DOI: https://doi.org/10.1080/14787210.2024.2345877
2024-04-24
Expert Review of Anti-infective Therapy
Abstract:Introduction Ventilator associated pneumonia (VAP) leads to an increase in morbidity, mortality, and healthcare costs. In addition to increased evidence from the latest European and American guidelines (published in 2017 and 2022, respectively), in the last two years, several important clinical experiences have added new prevention tools to be included to improve the management of VAP.
pharmacology & pharmacy,infectious diseases,microbiology
What problem does this paper attempt to address?